Prevalence of comorbid major depressive disorder in Type 2 diabetes : a meta-analysis of comparative and epidemiological studies
© 2019 Diabetes UK..
AIMS: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis.
METHODS: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model.
RESULTS: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5% (95% CI 7.9-25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95% CI 1.38-2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder.
CONCLUSIONS: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Diabetic medicine : a journal of the British Diabetic Association - 36(2019), 8 vom: 24. Aug., Seite 961-969 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 13.04.2020 Date Revised 13.04.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/dme.14042 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297457365 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297457365 | ||
| 003 | DE-627 | ||
| 005 | 20231225092031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dme.14042 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0991.xml |
| 035 | |a (DE-627)NLM297457365 | ||
| 035 | |a (NLM)31127631 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevalence of comorbid major depressive disorder in Type 2 diabetes |b a meta-analysis of comparative and epidemiological studies |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.04.2020 | ||
| 500 | |a Date Revised 13.04.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 Diabetes UK. | ||
| 520 | |a AIMS: To examine the average point prevalence of major depressive disorder in people with Type 2 diabetes and its associated factors in a comprehensive meta-analysis | ||
| 520 | |a METHODS: Two researchers independently conducted a systematic literature search of PubMed, EMBASE, PsycINFO and Cochrane databases. Studies reporting the prevalence of major depressive disorder in people with Type 2 diabetes were identified and analysed using a random-effects model | ||
| 520 | |a RESULTS: A total of 26 studies meeting the inclusion criteria were included in the study. The point prevalence of major depressive disorder was 14.5% (95% CI 7.9-25.3; I²=99.65). People with Type 2 diabetes were more likely to have major depressive disorder compared with the general population (odds ratio 1.73, 95% CI 1.38-2.16). Subgroup and meta-regression analyses showed that study site, study type, diagnostic criteria and age significantly moderated the prevalence of major depressive disorder | ||
| 520 | |a CONCLUSIONS: In this meta-analysis, the average point prevalence of major depressive disorder in people with Type 2 diabetes was high. Routine screening and more effective interventions should be implemented for this population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Systematic Review | |
| 700 | 1 | |a Wang, S |e verfasserin |4 aut | |
| 700 | 1 | |a Zong, Q-Q |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Q |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, C H |e verfasserin |4 aut | |
| 700 | 1 | |a Ungvari, G S |e verfasserin |4 aut | |
| 700 | 1 | |a Xiang, Y-T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetic medicine : a journal of the British Diabetic Association |d 1993 |g 36(2019), 8 vom: 24. Aug., Seite 961-969 |w (DE-627)NLM012664030 |x 1464-5491 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2019 |g number:8 |g day:24 |g month:08 |g pages:961-969 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dme.14042 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2019 |e 8 |b 24 |c 08 |h 961-969 | ||